The Experimental Irradiation Platform to serve the Île-de-France scientific community
Genopole is making available to the Île-de-France scientific community an Experimental Irradiation Platform equipped with a state of the art generator
15 February 2024
Read the articleThree Gene.iO whiz kids rewarded for their innovations
Three Gene.iO whiz kids, Alga Biologics, Fungu'it and Alt Biotech, rewarded for their innovations. Alga Biologics was among the 35 start-ups included in the French Blue Tech Index. Fungu'it and Alt Biotech, were selected to participate in 212 Founders, a start-up accompaniment and financing program by CDG Invest.
25 January 2024
Read the articleFelome Launches the Commercialization of Genetic Analyses for Companion Cats
Felome will begin the commercialization of a service offering genetic analyses for companion cats, to reveal their predispositions to over 50 diseases, identify their main physical traits, and their similarities with 14 types of breeds.
15 January 2024
Read the articleA prize and gold for the 2023 Évry Paris-Saclay iGEM team
The international synthetic biology competition iGEM celebrated its 20th anniversary. From across the globe, the event drew more than 7,000 students in 400 teams from 66 countries. Genopole was there, among other actors in synthetic biology, to present the biocluster's advantages at its stand, and support the 17 students of the Évry Paris-Saclay team and their outstanding project, OptoGenEYEsis.
22 November 2023
Read the articleAn exploratory mission to Japan and South Korea for Genopole
Genopole sent a team to Japan and South Korea to present itself and several of its accompanied businesses to major pharmaceutical corporations, investors and Asian bioclusters curious about biotechnological innovations and open to international partnerships.
20 November 2023
Read the articleIBISC – Structure prediction for RNA complexes
passes a milestone in structure prediction for RNA complexes, key players in cell biology.
06 November 2023
Read the articleIBISC: A first predictive tool for the emerging field of bifunctional RNA
The IBISC laboratory has developed IRSOM2, an unprecedented bioinformatics tool for the prediction of bifunctional RNA, a relatively recently discovered class of RNA showing both an ability to code for proteins and an ability to perform biological roles.
31 August 2023
Read the articleSABNP & Synsight: discovery of new medicines
SABNP and Synsight have validated an integrated, drug discovery approach uniting informatics, structural biology and in vivo exploration.
10 May 2023
Read the articleGenopole strengthens its ties with the Research Triangle Park
From Monday March 20 to Thursday March 24, Genopole's Partnership & Business Development team visited the Research Triangle Park biopark in North Carolina to strengthen scientific and industrial collaborations.
19 April 2023
Read the articleLambe: Detecting coagulation biomarkers with a natural nanopore
The Lambe laboratory showed proof of concept for a coagulation biomarker detection technology based on a natural nanopore.
09 March 2023
Read the articleGenoscope: Biomanufacturing with bacteria
A team led by Andrew Tolonen has developed a method to optimize the genetic engineering of Clostridium genus bacteria for biotech applications
15 February 2023
Read the articleShining light on a key mechanism of Duchenne muscular dystrophy
A Genethon team has provided new insights on a complex genetic mechanism involved in mitochondrial dysfunction in Duchenne muscular dystrophy.
16 December 2022
Read the articleA trio of genome sites associated with arterial hypertension
Researchers from the CNRGH and PARCC have identified three loci associated with an increased risk of developing primary hyperaldosteronism, a leading cause of arterial hypertension.
12 December 2022
Read the articleThe story of the domestic donkey told by its genome
Genoscope participated in the sequencing of the DNA of 250 donkeys in a study revealing the domestication of this species highly contributive to human activities to this day.
14 November 2022
Read the articleGalaxy-SynBioCAD: accelerating the arrival of green chemistry
Conceived by the Genomics Metabolics Unit, Galaxy-SynBioCAD accelerates biological design and engineering for the production of next generation chemical compounds.
28 October 2022
Read the article